Literature DB >> 8878224

Cryptococcosis in human immunodeficiency virus-infected children.

C E Gonzalez1, D Shetty, L L Lewis, B U Mueller, P A Pizzo, T J Walsh.   

Abstract

BACKGROUND: Cryptococcosis is a common opportunistic infection in adults with AIDS. Few cases of cryptococcosis complicating pediatric AIDS have been reported. To our knowledge there are no studies that describe the epidemiology, clinical manifestations and outcome of cryptococcosis in a large population of HIV-infected children.
METHODS: We identified the cases of cryptococcosis through a retrospective review of the hospital records of the 473 HIV-infected children prospectively monitored in the Pediatric Branch of the National Cancer Institute during the 8 years from 1987 to 1995.
RESULTS: Four (0.85%) patients developed cryptococcosis during the study period. All patients had profound depression of the absolute CD4 counts, a history of previous opportunistic infections, and onset of cryptococcosis in the second decade of life. Cryptococcosis developed as a disseminated infection or a localized process of the lungs. Intermittent fever was the most common presenting manifestation. Serum cryptococcal antigen was positive in all patients and gradually declined after the institution of the antifungal therapy. All patients were treated with amphotericin B with or without flucytosine as initial therapy. Suppressive therapy consisted of fluconazole with or without flucytosine. There were no deaths due to Cryptococcus neoformans.
CONCLUSIONS: Cryptococcosis is an infrequent yet treatable opportunistic infection of advanced pediatric AIDS that may present with subtle manifestations and warrants careful consideration in the evaluation of febrile HIV-infected children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878224     DOI: 10.1097/00006454-199609000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Cryptococcal osteomyelitis in an adolescent survivor of T-cell acute lymphoblastic leukemia.

Authors:  Djin-Ye Oh; P Pallavi Madhusoodhan; Deborah J Springer; Kenneth Inglima; Ali A Chaudhri; Joseph Heitman; Elizabeth A Raetz; Alka Khaitan; Mona Rigaud
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

Review 3.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

4.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

5.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

6.  Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.

Authors:  A Sarah Walker; Andrew J Prendergast; Peter Mugyenyi; Paula Munderi; James Hakim; Addy Kekitiinwa; Elly Katabira; Charles F Gilks; Cissy Kityo; Patricia Nahirya-Ntege; Kusum Nathoo; Diana M Gibb
Journal:  Clin Infect Dis       Date:  2012-09-12       Impact factor: 9.079

Review 7.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

Review 8.  Cryptococcosis in Colombian children and literature review.

Authors:  Jairo Lizarazo; Patricia Escandón; Clara Inés Agudelo; Elizabeth Castañeda
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-09       Impact factor: 2.743

9.  A case-control study of risk factors for HIV-negative children with cryptococcal meningitis in Shi Jiazhuang, China.

Authors:  Jianhua Guo; Jikun Zhou; Shiyong Zhang; Xin Zhang; Jing Li; Yinqi Sun; Shunxiang Qi
Journal:  BMC Infect Dis       Date:  2012-12-26       Impact factor: 3.090

10.  Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.

Authors:  Andrea J Curtis; Catherine S Marshall; Tim Spelman; Jane Greig; Julian H Elliot; Leslie Shanks; Philipp Du Cros; Esther C Casas; Marcio Silveria Da Fonseca; Daniel P O'Brien
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.